Histopathologic characteristics of EBV-LPD
| Characteristic . | EBV-CTL recipients (n = 19) . | DLI recipients (n = 30) . |
|---|---|---|
| Time to EBV-LPD after HSCT, d, median (IQR) | 91 (64-247) | 114 (84-138) |
| Histology | ||
| DLBL | 16 | 29 |
| FLH | 1 | 0 |
| PLPL | 0 | 1 |
| NHL | 1 | 0 |
| HD | 1 | 0 |
| Origin | ||
| Host | 1 | 1 |
| Donor | 10 | 14 |
| Mixed | 1 | 3 |
| Unknown | 7 | 12 |
| Clonality | ||
| EBV clonal | 7 of 7 tested | 16 of 18 tested |
| Ig clonal | 11 of 11 tested | 19 of 22 tested |
| Characteristic . | EBV-CTL recipients (n = 19) . | DLI recipients (n = 30) . |
|---|---|---|
| Time to EBV-LPD after HSCT, d, median (IQR) | 91 (64-247) | 114 (84-138) |
| Histology | ||
| DLBL | 16 | 29 |
| FLH | 1 | 0 |
| PLPL | 0 | 1 |
| NHL | 1 | 0 |
| HD | 1 | 0 |
| Origin | ||
| Host | 1 | 1 |
| Donor | 10 | 14 |
| Mixed | 1 | 3 |
| Unknown | 7 | 12 |
| Clonality | ||
| EBV clonal | 7 of 7 tested | 16 of 18 tested |
| Ig clonal | 11 of 11 tested | 19 of 22 tested |
FLH indicates focal lymphoid hyperplasia; PLPC, polymorphic lymphoplasmocytic lymphoma; NHL, nonHodgkin lymphoma; and HD, Hodgkin disease.